Changes in the epidemiological landscape of invasive candidiasis
The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …
of the changes and the implications for current and future diagnosis and treatment. The …
Candida parapsilosis: from genes to the bedside
Patients with suppressed immunity are at the highest risk for hospital-acquired infections.
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …
High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis
The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and
fungi,. Although the composition of bacterial constituents has been linked to immune …
fungi,. Although the composition of bacterial constituents has been linked to immune …
Epidemiology and risk factors for invasive candidiasis
N Yapar - Therapeutics and clinical risk management, 2014 - Taylor & Francis
The number of immunosuppressive patients has increased significantly in recent years.
These patients are at risk for opportunistic infections, especially fungal infections …
These patients are at risk for opportunistic infections, especially fungal infections …
Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria
Antibiotics are a modifiable iatrogenic risk factor for the most common human nosocomial
fungal infection, invasive candidiasis, yet the underlying mechanisms remain elusive. We …
fungal infection, invasive candidiasis, yet the underlying mechanisms remain elusive. We …
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy …
This analysis describes the epidemiology and outcomes of invasive candidiasis caused by
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)
O Lortholary, C Renaudat, K Sitbon, Y Madec… - Intensive care …, 2014 - Springer
Purpose To analyze trends in incidence and mortality of candidemia in intensive care units
(ICUs) vs. non-ICU hospitalized patients and to determine risk factors for infection by specific …
(ICUs) vs. non-ICU hospitalized patients and to determine risk factors for infection by specific …
[HTML][HTML] How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing …
Background EUCAST has revised the definition of the susceptibility category I from
'Intermediate'to 'Susceptible, Increased exposure'. This implies that I can be used where the …
'Intermediate'to 'Susceptible, Increased exposure'. This implies that I can be used where the …
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008
This analysis describes the epidemiology and outcomes of candidemia in patients enrolled
in the Prospective Antifungal Therapy Alliance (PATH Alliance®) registry from 2004 to 2008 …
in the Prospective Antifungal Therapy Alliance (PATH Alliance®) registry from 2004 to 2008 …
Echinocandin resistance: an emerging clinical problem?
Echinocandin resistance is increasingly encountered and its occurrence makes
susceptibility testing essential, particularly in patients with prior exposure. The further …
susceptibility testing essential, particularly in patients with prior exposure. The further …